Convatec Group PLC: Results of AGM

Convatec Group PLC

16 May 2024

 

Convatec Group Plc

Results of Annual General Meeting

London, United Kingdom (16 May 2024) - Poll Result

Convatec Group Plc ("Convatec") held its Annual General Meeting today ("AGM"). The results of the poll held in relation to the resolutions proposed at the AGM are set out below

		For (see note 2)		Against (see note 2)		Votes Total (excluding withheld)	% of ISC Voted	Votes Witheld
Resolution		No of shares	%	No of Shares	%
1	To receive the Annual Report and Accounts 2023	1,852,466,756	100.00%	353	0.00%	1,852,467,109	90.37%	1,291,713
2	To approve the Directors' Remuneration Report	1,813,185,796	98.24%	32,521,511	1.76%	1,845,707,307	90.04%	8,051,515
3	To declare Final Dividend	1,853,744,153	100.00%	12,049	0.00%	1,853,756,202	90.44%	2,620
4	To re-elect Dr John McAdam as a Director	1,847,283,011	99.65%	6,442,175	0.35%	1,853,725,186	90.43%	33,636
5	To re-elect Karim Bitar as a Director	1,848,145,807	99.70%	5,582,073	0.30%	1,853,727,880	90.44%	30,942
6	To re-elect Jonny Mason as a Director	1,848,076,960	99.70%	5,632,063	0.30%	1,853,709,023	90.43%	49,799
7	To re-elect Margaret Ewing as a Director	1,816,225,341	97.98%	37,483,741	2.02%	1,853,709,082	90.43%	49,740
8	To re-elect Brian May as a Director	1,846,602,408	99.62%	7,118,004	0.38%	1,853,720,412	90.43%	38,410
9	To re-elect Professor Constantin Coussios as a Director	1,846,585,982	99.61%	7,143,987	0.39%	1,853,729,969	90.44%	28,853
10	To re-elect Heather Mason as a Director	1,805,072,326	97.38%	48,629,636	2.62%	1,853,701,962	90.43%	56,860
11	To re-elect Kim Lody as a Director	1,846,589,957	99.62%	7,117,950	0.38%	1,853,707,907	90.43%	50,915
12	To re-elect Sharon O'Keefe as a Director	1,846,493,634	99.61%	7,226,778	0.39%	1,853,720,412	90.43%	38,410
13	To re-appoint Deloitte LLP as auditors	1,851,179,389	99.98%	440,502	0.02%	1,851,619,891	90.33%	2,137,431
14	To authorise the Directors to agree the auditors' remuneration	1,853,715,114	100.00%	19,198	0.00%	1,853,734,312	90.44%	24,510
15	To approve an amendment to the Company's LTIP rules to reflect the increased maximum award limit set out for executive directors in the Company's prevailing Directors' Remuneration policy.	1,837,845,100	99.14%	15,882,668	0.86%	1,853,727,768	90.44%	31,054
16	To authorise political donations and political expenditure	1,836,103,687	99.07%	17,229,247	0.93%	1,853,332,934	90.42%	425,888
17	To authorise the Directors to allot shares	1,710,658,359	92.28%	143,073,563	7.72%	1,853,731,922	90.44%	26,900
18	To authorise the Directors to disapply pre-emption rights*	1,711,441,065	92.34%	142,042,010	7.66%	1,853,483,075	90.42%	275,747
19	To authorise the Directors to disapply pre-emption rights in connection with an acquisition or specified capital investment*	1,664,945,067	90.18%	181,388,202	9.82%	1,846,333,269	90.07%	7,425,553
20	To authorise the Directors to make market purchases of own shares*	1,850,913,656	99.88%	2,233,348	0.12%	1,853,147,004	90.41%	611,818
21	To authorise the calling of a general meetings on 14 clear days' notice*	1,795,351,922	96.85%	58,406,900	3.15%	1,853,758,822	90.44%	0

*Special Resolution

NOTES:

1.   All resolutions were passed.

2.   Votes "For" and "Against" are expressed as a percentage of votes received.

3.   A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

4.   Total number of shares in issue is 2,049,789,559 (90.44% of capital was voted).

5.   Computershare acted as scrutineer of the poll on all resolutions.

In accordance with Listing Rule 9.6.2, copies of the resolutions that do not constitute ordinary business that were passed at the Annual General Meeting have been submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.                      

Enquiries  

Ria Banerjee, Group Deputy Company Secretary                                          [phone] 

[e-mail]  

Convatec Group Plc's LEI code is 213800LS272L4FIDOH92  

About Convatec  
 

Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence care and infusion care. With around 10,000 colleagues, we provide our products and services in almost 100 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Group revenues in 2023 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE: CTEC). To learn more about Convatec, please visit www.convatecgroup.com

# # #

END

 

END